Cigna Corporation provides insurance and related products and services.
Undervalued with proven track record.
Share Price & News
How has Cigna's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CI has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: CI underperformed the US Healthcare industry which returned 17.8% over the past year.
Return vs Market: CI underperformed the US Market which returned 17.1% over the past year.
Price Volatility Vs. Market
How volatile is Cigna's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StCan You Imagine How Cigna's (NYSE:CI) Shareholders Feel About The 22% Share Price Increase?
3 weeks ago | Simply Wall StHere's Why Cigna (NYSE:CI) Can Manage Its Debt Responsibly
1 month ago | Simply Wall StHow Much Is Cigna Corporation (NYSE:CI) CEO Getting Paid?
Is Cigna undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CI ($184.32) is trading below our estimate of fair value ($389.41)
Significantly Below Fair Value: CI is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CI is good value based on its PE Ratio (13x) compared to the US Healthcare industry average (26.1x).
PE vs Market: CI is good value based on its PE Ratio (13x) compared to the US market (19.1x).
Price to Earnings Growth Ratio
PEG Ratio: CI is poor value based on its PEG Ratio (1.4x)
Price to Book Ratio
PB vs Industry: CI is good value based on its PB Ratio (1.4x) compared to the US Healthcare industry average (3.1x).
How is Cigna forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CI's forecast earnings growth (9.3% per year) is above the savings rate (2.2%).
Earnings vs Market: CI's earnings (9.3% per year) are forecast to grow slower than the US market (24.1% per year).
High Growth Earnings: CI's earnings are forecast to grow, but not significantly.
Revenue vs Market: CI's revenue (4.8% per year) is forecast to grow slower than the US market (9.4% per year).
High Growth Revenue: CI's revenue (4.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CI's Return on Equity is forecast to be low in 3 years time (15.7%).
How has Cigna performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CI has high quality earnings.
Growing Profit Margin: CI's current net profit margins (3.4%) are lower than last year (3.6%).
Past Earnings Growth Analysis
Earnings Trend: CI's earnings have grown significantly by 21.6% per year over the past 5 years.
Accelerating Growth: CI's earnings growth over the past year (42.3%) exceeds its 5-year average (21.6% per year).
Earnings vs Industry: CI earnings growth over the past year (42.3%) exceeded the Healthcare industry 21.8%.
Return on Equity
High ROE: CI's Return on Equity (11.2%) is considered low.
How is Cigna's financial position?
Financial Position Analysis
Short Term Liabilities: CI's short term assets ($34.9B) do not cover its short term liabilities ($42.2B).
Long Term Liabilities: CI's short term assets ($34.9B) do not cover its long term liabilities ($70.0B).
Debt to Equity History and Analysis
Debt Level: CI's debt to equity ratio (76.9%) is considered high.
Reducing Debt: CI's debt to equity ratio has increased from 45.6% to 76.9% over the past 5 years.
Debt Coverage: CI's debt is well covered by operating cash flow (28.6%).
Interest Coverage: CI's interest payments on its debt are well covered by EBIT (6.2x coverage).
What is Cigna current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CI's dividend (0.021%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.6%).
High Dividend: CI's dividend (0.021%) is low compared to the top 25% of dividend payers in the US market (4.3%).
Stability and Growth of Payments
Stable Dividend: CI is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: CI is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: CI is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
David Cordani (55 yo)
Mr. David Michael Cordani has been the Chief Executive Officer and President of Cigna Corporation since December 25, 2009 and June 2008 respectively and has been its Director since October 2009. Mr. Cordan ...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD19.30M) is above average for companies of similar size in the US market ($USD11.36M).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
|Executive VP & CFO||3.17yrs||US$6.14m||0.0070% |
|Executive VP & General Counsel||9.17yrs||US$4.56m||0.0079% |
|President of Strategy & Solutions||1.75yrs||US$6.20m||0.013% |
|Executive VP & Chief Customer Officer||7.25yrs||US$4.61m||0.0063% |
|President of Health Services||1.67yrs||US$23.54m||0.021% |
|Senior VP of Tax & Chief Accounting Officer||11.08yrs||no data||0.0018% |
|Executive VP & Global Chief Information Officer||9.33yrs||no data||0.014% |
|Vice President of Investor Relations||no data||no data||no data|
|Global Chief Marketing Officer & Executive VP||0.42yr||no data||0.00036% |
|Executive Vice President of Human Resources & Services||17yrs||US$3.51m||0.016% |
|Chief Counsel of Corporate Law and Vice President||8.92yrs||no data||no data|
Experienced Management: CI's management team is seasoned and experienced (8.9 years average tenure).
|Chairman Emeritus||no data||US$18.82m||no data|
|Independent Director||15.5yrs||US$341.39k||0.0066% |
|Independent Director||9.08yrs||US$310.37k||0.0086% |
|Independent Director||1.67yrs||US$335.37k||0.0013% |
|Independent Director||15.08yrs||US$336.44k||0.013% |
|Independent Director||13.33yrs||US$317.15k||0.0051% |
|Independent Chairman of the Board||10.67yrs||US$575.35k||0.0050% |
|Independent Director||1.67yrs||US$310.37k||0.0034% |
|Independent Director||11.58yrs||US$335.37k||0.0076% |
|Independent Director||1.67yrs||US$310.37k||0.00050% |
|Independent Director||1.67yrs||US$310.37k||0.00064% |
Experienced Board: CI's board of directors are seasoned and experienced ( 10.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CI insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cigna Corporation's company bio, employee growth, exchange listings and data sources
- Name: Cigna Corporation
- Ticker: CI
- Exchange: NYSE
- Founded: 1792
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$67.682b
- Shares outstanding: 367.20m
- Website: https://www.cigna.com
Number of Employees
- Cigna Corporation
- 900 Cottage Grove Road
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CI||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||Apr 1982|
|CI *||BMV (Bolsa Mexicana de Valores)||Yes||Common Stock||MX||MXN||Apr 1982|
|CGN||XTRA (XETRA Trading Platform)||Yes||Common Stock||DE||EUR||Apr 1982|
|CIGN||WBAG (Wiener Boerse AG)||Yes||Common Stock||AT||EUR||Apr 1982|
|CGN||ETLX (Eurotlx)||Yes||Common Stock||IT||EUR||Apr 1982|
|C1IC34||BOVESPA (Bolsa de Valores de Sao Paulo)||BDR EACH 24 REPR 1 SHS UNSPON||BR||BRL||Jan 2020|
Cigna Corporation provides insurance and related products and services. It operates through Health Services, Integrated Medical, International Markets, and Group Disability and Other segments. The Health S ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/08/12 23:32|
|End of Day Share Price||2020/08/12 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.